Aequor partners with companies within the life sciences industry on critical technology initiatives to help them respond to the market demands of today and opportunities of tomorrow, addressing the areas of R&D, supply chain, sales and marketing and compliance.

We provide market coverage of sectors such as Electronic Medical Records (EMR), cGMP compliance and the enhanced security of patient information.

Technology is fueling major changes within the life sciences industry – from Electronic Data Capture and Closed Loop Marketing to industry initiatives such as CRIX, CDISC, the FDA’s critical path and DERP. The practice of bio-informatics is set to lead a new wave of outsourcing investment to the pharmaceutical, biotechnology and life sciences sectors.

Industry Challenges

• Depleting drug pipelines
• Slowing drug discoveries
• Rising development costs (up to $ 1.5 billion)
• Slower time to market
• Shrinking Margins
• Intense competition
• Diligence in compliance
• Insufficient leveraging of off-shoring opportunities

Aequor Partnership Benefits

• Fourth generation outsourcing model
• Package implementation and custom development
• Life sciences domain expertise
• Pharmaceutical value chain expertise
• RAC-certified analysts with understanding of FDA and EMEA regulations
• Validated systems development and maintenance
• CMMi Level 3 certification
• SDLC processes mapped to CSV and other regulatory requirements
• Audited compliance by CROs, pharmaceutical companies and life sciences ISV firms